Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

De Foe A.

28 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 10 Mechanism of Action 8 Clinical Trial 7 Review Article 7 Receptor Pharmacology 7 Safety 7 General 4 Brain Imaging 4 Aging 4 Pharmacology 4 Addiction 3 Consciousness 3

Journals

RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia 4 PsyArXiv 4 bioRxiv 2 British journal of pharmacology 1 European archives of psychiatry and clinical neuroscience 1 Current Treatment Options in Psychiatry 1 Acta neuropsychiatrica 1 Expert review of clinical pharmacology 1

Publication history

Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology.British journal of pharmacology · 2026-07-01 Mapping cognitive-behavioral approach in psychedelic-assisted treatment: a systematic review across phases with classic and non-classic psychedelics.European archives of psychiatry and clinical neuroscience · 2026-06-01 Enhancing cGMP signaling with psilocybin reduces head twitch and restructures the synaptic proteome while maintaining antidepressant responsebioRxiv · 2026-03-10 The THRIVE Model of Psychedelic Integration: A Holistic Framework Bridging Indigenous Knowledge and Evidence-Based PracticeCurrent Treatment Options in Psychiatry · 2025-10-19 Therapeutic Use of Psilocybin in Depression: a Systematic Review of Clinical Evidence.Acta neuropsychiatrica · 2025-09-03 Psychedelic drugs for the treatment of substance use disorders.Expert review of clinical pharmacology · 2025-07-01 Deconstructing Psychedelic Phenomenology: A Thematic Analysis of Discrete Phases of the Psychedelic ExperienceBrain and Behavior · 2025-06-30 Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2025-05-01 Neurotoxic and Neuroprotective Effects of Psychedelics in a Human Neuroblastoma Cell ModelRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2025-01-01 Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulation in healthy humansmedRxiv · 2024-09-22 Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybinJournal of Drug Delivery Science and Technology · 2024-01-06 Brazilian Psychedelic Science and the Frontiers of PsychiatryJornal Brasileiro de Psiquiatria · 2024-01-01 In vivo mapping of pharmacologically induced functional reorganization onto the human brain's neurotransmitter landscape.Science advances · 2023-06-16 Classic psychedelic use and current meditation practice.Mindfulness · 2023-04-01 Predictors of Psychedelic Experience: A Thematic Analysis.Journal of psychoactive drugs · 2023-01-01 Cannabis-assisted psychotherapy for complex dissociative posttraumatic stress disorder: A case report.Frontiers in psychiatry · 2023-01-01 Psilocybin for Depression: From Credibility to Feasibility, What's Missing?Pharmaceuticals (Basel, Switzerland) · 2022-12-31 Mapping Pharmacologically-induced Functional Reorganisation onto the Brain’s Neurotransmitter LandscapebioRxiv · 2022-07-13 Psychedelic assisted therapy for major depressive disorder: Recent work and clinical directionsJournal of Psychedelic Studies · 2022-06-09 Production and extraction of psilocybin and psilocin from Psilocybe spp. mushroomsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2022-04-06 Evaluation of a quantitative analytical method for psilocin and psilocybin using HPLC-DADRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2022-04-06 Psylocybin and Psilocin as new tools to fight depression: an overview of the Pharmacodynamic and pharmacokinetic mechanismsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2022-04-06 Predictors of Psychedelic Experience: A Thematic AnalysisPsyArXiv · 2021-12-21 Predictors of Psychedelic Experience: A Thematic AnalysisPsyArXiv · 2021-12-21 Psychedelic Assisted Therapy for Major Depressive Disorder: A ReviewPsyArXiv · 2021-06-27 Psychedelic Assisted Therapy for Major Depressive Disorder: A ReviewPsyArXiv · 2021-06-27 Treating Addiction: Perspectives from EEG and Imaging Studies on Psychedelics.International review of neurobiology · 2016-01-01 The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network.PloS one · 2015-01-01

Author directory